Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia

Surgical Endoscopy

Volumn 25, Issue 6, 2011, Pages 1926-1932

  Roslin, Mitchell ^a   Damani, Tanuja ^a   Oren, Jonathan ^b   Andrews, Robert ^c   Yatco, Edward ^a   Shah, Paresh ^a  

^a LENOX HILL HOSPITAL   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Gastric bypass; Morbid obesity; Reactive hypoglycemia; Roux en Y gastric bypass

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; EATING DISORDER; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SCREENING TEST; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 80051693272     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-010-1489-9     Document Type: Article

References (33)

1. Manson JE, Skerret PJ, Greenland P, VanItallie TB (2004) The escalating pandemic s of obesity and sedentary lifestyle: a call to action by clinicians. Arch Intern Med 164:249-258. (Pubitemid 38176465)
2. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D (2003) Effect of laparoscopic Rouxen- Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467-484.
3. Torquati A, Lutfi R, Abumrad N, Richards WO (2005) Is Rouxen- Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg 9:1112-1116.
4. Parikh M, Ayoung-Chee P, Romanos E, Lewis N, Pachter HL, Fielding G, Ren C (2007) Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass and biliopancreatic diversion. J Am Coll Surg 205:631-635. (Pubitemid 47615490)
5. Alexandrides TK, Skroubis G, Kalfarentzos F (2007) Resolution of diabetes mellitus and metabolic syndrome following Roux-en- Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg 17:176-184. (Pubitemid 47091578)
6. Gumbs AA, Modlin IM, Ballantyne GH (2005) Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 15:462-473. (Pubitemid 40605067)
7. Service FJ, Natt N, Thompson GB, Grant CS, van Heerden JA, Andrews JC, Lorenz E, Terzic A, Lloyd RV (1999) Noninsulinoma pancreatogenous hypoglycemia:a novel syndrome of hyperinsulinemic hypoglycemic in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab 84:1582-1589. (Pubitemid 30644258)
8. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo- Clavell ML, Lloyd RV (2005) Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353:249-254. (Pubitemid 41058324)
9. Bantle JP, Ikramuddin S, Kellogg TA, Buchwald H (2007) Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes Surg 17:592-594. (Pubitemid 46945415)
10. Moreira RO, Moreira RBM, Machado NAM, Goncalves TB, Coutinho WF (2008) Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg 18:1618-1621.
11. Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V, Bonner-Weir S, Goldfine AB (2005) Severe hypoglycemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236-2240. (Pubitemid 41618912)
12. Clancy TE, Moore FD, Zinner MJ (2006) Post-gastric bypass hyperinsulinism with nesidioblastosis:subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastroint Surg 10:1116-1119. (Pubitemid 44332983)
13. Alvarez GC, Faria EN, Beck M, Girardon DT, Machado AC (2007) Laparoscopic spleen-preserving distal pancreatectomy as treatment for nesidioblastosis after gastric bypass surgery. Obes Surg 14:550-552. (Pubitemid 46850198)
14. De Leon DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA (2003) Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes 52:365-371. (Pubitemid 36173191)
15. List JF, Habener JF (2004) Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta cells. Am J Physiol Endocrinol Metab 286:E875-E881. (Pubitemid 38668807)
16. Brubaker PL, Drucker DJ (2004) Minireview: glucagon-like polypeptides regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system. Endocrinology 145:2653-2659. (Pubitemid 38686211)
17. Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R (2003) Glucagon-like peptide 1 inhibits cell apoptosis and proves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149-5158. (Pubitemid 37476040)
18. Meier JJ, Butler AE, Galasso R, Butler PC (2006) Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 29:1554-1559. (Pubitemid 44127580)
19. Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL, Goff DV (1981) Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34:362-366. (Pubitemid 11159124)
20. Kiens B, Richter EA (1996) Types of carbohydrate in an ordinary diet affect insulin action and muscle substrates in humans. Am J Clin Nutr 63:47-53. (Pubitemid 26005726)
21. Thomas DE, Elliott EJ, Baur L (2007) Low glycaemic index or low glycaemic load diets for overweight and obesity. Cochrane Database Syst Rev. doi:10.1002/14651858.CD005105.pub2. (Pubitemid 351805560)
22. Linner JH (1982) Comparative effectiveness of gastric bypass and gastroplasty. Arch Surg 117:695-700. (Pubitemid 12161832)
23. Laws HL, Piantadosi S (1980) Superior gastric reduction procedure for morbid obesity. A prospective randomized trial. Ann Surg 193:334-336.
24. Pories WJ, Flickinger EG, Meelheim D, Van Rij AM, Thomas FT (1982) The effectiveness of gastric bypass over gastric partition in morbid obesity: consequences of distal gastric and duodenal exclusion. Ann Surg 196:389-399. (Pubitemid 12030716)
25. Sugerman HJ, Starkey JV, Birkenhauer R (1987) A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 205:613-622.
26. Sugerman HJ, Wolper HL (1984) Failed gastroplasty for morbid obesity: revised gastroplasty vs. Roux-en-Y gastric bypass. Am J Surg 148:331-336.
27. Eckhauser FE, Knoll JA, Strodel WE (1983) Remedial surgery following failed gastroplasty for morbid obesity. Ann Surg 198:585-591. (Pubitemid 14225240)
28. Magro DO, Geloneze B, Delfini R, Pareja BC, Callejas F, Pareja JC (2008) Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg 18:648-651.
29. Christou NV, Look D, Maclean LD (2006) Weight gain after short-and long-limb gastric bypass in patients followed longer than 10 years. Ann Surg 244:734-740. (Pubitemid 44629947)
30. Loewen M, Barba C (2008) Endoscopic sclerotherpy for dilated gastrojejunostomy of failed gastric bypass. Surg Obes Relat Dis 4:539-542. (Pubitemid 352006162)
31. Thompson CC, Slattery J, Bundga ME, Lautz DB (2006) Preoral endoscopic reduction of dilated gastrojejunal anastomosis after Roux-en-Y gastric bypass: a possible new option for patients with weight regain. Surg Endosc 20:1744-1748. (Pubitemid 44715541)
32. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002) Plasma ghrelin levels after dietinduced weight loss or gastric bypass surgery. N Engl J Med 346:1623-1630. (Pubitemid 34755670)
33. Kalarchian MA, Marcus MD, Wilson GT, Labouvie EW, Brolin RE, LaMarca LB (2002) Binge eating among gastric bypass patients and long-term follow-up. Obes Surg 12:270-275. (Pubitemid 34442093)